Tech Company Financing Transactions
Esperas Pharma Funding Round
Fonds de solidarite FTQ and TVM Capital participated in a Series A venture round for Esperas Pharma. The round was recorded on 4/15/2015.
Transaction Overview
Company Name
Announced On
4/15/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3500 Blvd. De Maisonneuve West 902
Montréal QC, H3Z 1X5
Canada
Montréal QC, H3Z 1X5
Canada
Phone
Undisclosed
Email Address
Not Recorded
Overview
Esperas Pharma Inc. is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Ventures VII and Fonds de solidarité FTQ.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Caroline Fortier
Browse more venture capital transactions:
Prev: 4/15/2015: TreSensa venture capital transaction
Next: 4/15/2015: FinalCode venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs